カテゴリー： Infiniti Research TechNavio, 世界, 医療/バイオ

羊膜の世界市場2021年-2025年

【英語タイトル】Global Amniotic Membrane Market 2021-2025

Technavioが出版した調査資料（IRTNTR40730）・商品コード：IRTNTR40730
・発行会社（調査会社）：Technavio
・発行日：2021年5月21日
・ページ数：約120
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：北米、ヨーロッパ、アジア、その他
・産業分野：バイオ
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥365,000見積依頼/購入/質問フォーム
Five User（5名様閲覧用）USD3,000 ⇒換算￥438,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥584,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
テクナビオ社は、羊膜の世界市場規模が2021年から2025年まで年平均約12％成長し、954.86百万ドルに達すると予測しています。本調査レポートは、世界の羊膜市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、種類別（凍結保存羊膜、乾燥羊膜）分析、顧客状況、地域別状況、企業状況、企業分析など、以下の項目でまとめております。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・羊膜の世界市場規模：種類別（凍結保存羊膜、乾燥羊膜）
・顧客状況
・地域別状況
・企業状況
・企業分析
❖ レポートの概要 ❖

Global Amniotic Membrane Market 2021-2025

Technavio has been monitoring the amniotic membrane market and it is poised to grow by $ 954.86 million during 2021-2025, progressing at a CAGR of about 12% during the forecast period. Our report on the amniotic membrane market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the extensive use of amniotic membrane transplantation in ophthalmic surgeries and the high demand for amniotic membrane in wound repair and reconstruction. In addition, the extensive use of amniotic membrane transplantation in ophthalmic surgeries is anticipated to boost the growth of the market as well.

The amniotic membrane market analysis includes the type segment and geographic landscape.
Technavio’s amniotic membrane market is segmented as below:

By Type
• Cryopreserved amniotic membrane
• Dehydrated amniotic membrane

By Geography
• North America
• Europe
• Asia
• ROW

This study identifies the rising demand for biocompatible scaffolds as one of the prime reasons driving the amniotic membrane market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on amniotic membrane market covers the following areas:
• Amniotic membrane market sizing
• Amniotic membrane market forecast
• Amniotic membrane market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading amniotic membrane market vendors that include Celularity Inc., Stryker Corp., Surgenex LLC, Katena Products Inc., MiMedx Group Inc., NuVision Biotherapies Ltd., Orthofix Medical Inc.TissueTech Inc., Integra LifeSciences Holdings Corp., and Human Regenerative Technologies LLC. Also, the amniotic membrane market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/amniotic-membrane-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

❖ レポートの目次 ❖

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Type
o Market segments
o Comparison by Type
o Cryopreserved amniotic membrane – Market size and forecast 2020-2025
o Dehydrated amniotic membrane – Market size and forecast 2020-2025
o Market opportunity by Type
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o Asia – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Celularity Inc.
o Human Regenerative Technologies LLC
o Integra LifeSciences Holdings Corp.
o Katena Products Inc.
o MiMedx Group Inc.
o NuVision Biotherapies Ltd.
o Orthofix Medical Inc.
o Stryker Corp.
o Surgenex LLC
o TissueTech Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2020 – 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 – 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2020
• 21: Type – Market share 2020-2025 (%)
• 22: Comparison by Type
• 23: Cryopreserved amniotic membrane – Market size and forecast 2020-2025 ($ million)
• 24: Cryopreserved amniotic membrane – Year-over-year growth 2020-2025 (%)
• 25: Dehydrated amniotic membrane – Market size and forecast 2020-2025 ($ million)
• 26: Dehydrated amniotic membrane – Year-over-year growth 2020-2025 (%)
• 27: Market opportunity by Type
• 28: Customer landscape
• 29: Market share by geography 2020-2025 (%)
• 30: Geographic comparison
• 31: North America – Market size and forecast 2020-2025 ($ million)
• 32: North America – Year-over-year growth 2020-2025 (%)
• 33: Europe – Market size and forecast 2020-2025 ($ million)
• 34: Europe – Year-over-year growth 2020-2025 (%)
• 35: Asia – Market size and forecast 2020-2025 ($ million)
• 36: Asia – Year-over-year growth 2020-2025 (%)
• 37: ROW – Market size and forecast 2020-2025 ($ million)
• 38: ROW – Year-over-year growth 2020-2025 (%)
• 39: Key leading countries
• 40: Market opportunity by geography ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Celularity Inc. – Overview
• 48: Celularity Inc. – Product and service
• 49: Celularity Inc. – Key offerings
• 50: Celularity Inc. – Key customers
• 51: Celularity Inc. – Segment focus
• 52: Human Regenerative Technologies LLC – Overview
• 53: Human Regenerative Technologies LLC – Product and service
• 54: Human Regenerative Technologies LLC – Key offerings
• 55: Human Regenerative Technologies LLC – Key customers
• 56: Human Regenerative Technologies LLC – Segment focus
• 57: Integra LifeSciences Holdings Corp. – Overview
• 58: Integra LifeSciences Holdings Corp. – Business segments
• 59: Integra LifeSciences Holdings Corp. – Key offerings
• 60: Integra LifeSciences Holdings Corp. – Key customers
• 61: Integra LifeSciences Holdings Corp. – Segment focus
• 62: Katena Products Inc. – Overview
• 63: Katena Products Inc. – Product and service
• 64: Katena Products Inc. – Key offerings
• 65: Katena Products Inc. – Key customers
• 66: Katena Products Inc. – Segment focus
• 67: MiMedx Group Inc. – Overview
• 68: MiMedx Group Inc. – Business segments
• 69: MiMedx Group Inc. – Key offerings
• 70: MiMedx Group Inc. – Key customers
• 71: MiMedx Group Inc. – Segment focus
• 72: NuVision Biotherapies Ltd. – Overview
• 73: NuVision Biotherapies Ltd. – Product and service
• 74: NuVision Biotherapies Ltd. – Key offerings
• 75: NuVision Biotherapies Ltd. – Key customers
• 76: NuVision Biotherapies Ltd. – Segment focus
• 77: Orthofix Medical Inc. – Overview
• 78: Orthofix Medical Inc. – Business segments
• 79: Orthofix Medical Inc. – Key offerings
• 80: Orthofix Medical Inc. – Key customers
• 81: Orthofix Medical Inc. – Segment focus
• 82: Stryker Corp. – Overview
• 83: Stryker Corp. – Business segments
• 84: Stryker Corp. – Key offerings
• 85: Stryker Corp. – Key customers
• 86: Stryker Corp. – Segment focus
• 87: Surgenex LLC – Overview
• 88: Surgenex LLC – Product and service
• 89: Surgenex LLC – Key offerings
• 90: Surgenex LLC – Key customers
• 91: Surgenex LLC – Segment focus
• 92: TissueTech Inc. – Overview
• 93: TissueTech Inc. – Product and service
• 94: TissueTech Inc. – Key offerings
• 95: TissueTech Inc. – Key customers
• 96: TissueTech Inc. – Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations



❖ 掲載企業 ❖

Celularity Inc., Stryker Corp., Surgenex LLC, Katena Products Inc., MiMedx Group Inc., NuVision Biotherapies Ltd., Orthofix Medical Inc.TissueTech Inc., Integra LifeSciences Holdings Corp., Human Regenerative Technologies LLC

★調査レポート[羊膜の世界市場2021年-2025年] (コード：IRTNTR40730)販売に関する免責事項を必ずご確認ください。
★調査レポート[羊膜の世界市場2021年-2025年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 関節再建装置の世界市場2021年-2025年
    IRTNTR45002 / Technavio / 2021年9月20日 / テクナビオ社は、関節再建装置の世界市場規模が2021年～2025年まで年平均5％成長し、55.8億ドルに達すると予測しています。本市場調査レポートでは、世界の関節再建装置市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別（膝関節置換術、外傷・四肢、股関節置換術）分析、顧客状況、地域別状況、企業状況、企業分析など、以下の構成でまとめております。 ・エグゼクティブサマリー...
  • GaN無線周波数装置の世界市場2021年-2025年
    IRTNTR70990 / Technavio / 2021年11月26日 / テクナビオ社は、GaN無線周波数装置の世界市場規模が2021年～2025年まで10.6億ドルに達すると予測しています。本市場調査レポートでは、世界のGaN無線周波数装置市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、用途別（セルラーインフラストラクチャー、防衛用、CATV、その他）分析、顧客状況、地域別状況、企業状況、企業分析などの項目を掲載しています。 ・エグゼクティブサマリー...
  • 創傷ケアリーダーの世界市場2021年-2025年
    IRTNTR71136 / Technavio / 2021年12月9日 / テクナビオ社は、創傷ケアリーダーの世界市場規模が2021年から2025年までに47.7億ドルに達すると予測しています。本調査レポートは、世界の創傷ケアリーダー市場を調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別（創傷被覆材、手術創ケア、従来型創傷ケア、治療装置＆治癒剤、創傷管理製品）分析、顧客状況、地域別状況、企業状況、企業分析など、以下の内容でまとめております。 ・エグゼクティブサマリー...

    • ◆H&Iグローバルリサーチのお客様（例）◆